Rank #1418ORGO

Organogenesis Holdings Inc.

$3.98

3.65% (Daily)

Market Cap

$505.11M

Revenue

$465.22M

Rank by MCap

#1418

Sector

Healthcare

Industry

Drug Manufacturers - Specialty & Generic

CEO

Mr. Gary S. Gillheeney Sr.

Headquarters

Canton, MA

Employees

869

About Organogenesis Holdings Inc.

Organogenesis Holdings Inc., a regenerative medicine company, develops, manufactures, and commercializes products for the advanced wound care, and surgical and sports medicine markets in the United States. The company's advanced wound care products include Affinity and Novachor, which are amnion and chorion placental allografts for use in the care of chronic and acute wounds as protective barriers and extracellular matrix (ECM) scaffolds; Apligraf, a bioengineered bi-layered skin substitute f...